0 Valutazioni

ID

13021

Descrizione

Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00275015

collegamento

https://clinicaltrials.gov/show/NCT00275015

Keywords

  1. 12/01/16 12/01/16 -
Titolare del copyright

CC BY-NC 3.0

Caricato su

12 gennaio 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :


Non ci sono commenti

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Leukemia NCT00275015

Eligibility Leukemia NCT00275015

  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00275015
Criteria
Descrizione

Criteria

patients with chronic lymphocytic leukemia, meeting 1 of the following criteria:
Descrizione

CLL

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0023434 (Chronic Lymphocytic Leukemia)
SNOMED
51092000
LOINC
LP34550-1
binet stage b or c disease
Descrizione

binet stage

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1511118 (Binet Staging System)
binet stage a disease and at high risk for disease progression, defined as the following:
Descrizione

binet stage a disease and at high risk for disease progression

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1511118 (Binet Staging System)
non-nodular marrow infiltration or lymphocyte doubling time < 12 months
Descrizione

non-nodular marrow infiltration or lymphocyte doubling time < 12 months

Tipo di dati

boolean

Alias
UMLS CUI [1]
C3854434 (Bone marrow infiltration)
UMLS CUI [2]
C2986483 (Doubling Time)
thymidine kinase > 7.0 u/l or ß-2-microglobulin > 3.5 mg/l
Descrizione

thymidine kinase, ß-2-microglobulin

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0040078 (Thymidine Kinase)
SNOMED
61588000
UMLS CUI [2]
C0005149 (beta-2 Microglobulin)
SNOMED
90945000
polymerase chain reaction-amplifiable clonal cdriii rearrangement of the igv_h
Descrizione

polymerase chain reaction-amplifiable clonal cdriii rearrangement of the igv_h

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0887928 (Complementarity Determining Region 3)
ecog performance status 0-1
Descrizione

ecog performance status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1520224 (ECOG performance status)
SNOMED
423740007
no concurrent disease resulting in major organ dysfunction
Descrizione

no concurrent disease resulting in major organ dysfunction

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0009488 (Comorbidity)
no prior combination therapy comprising melphalan, dexamethasone, carmustine, cytarabine, and etoposide (dexa-beam)
Descrizione

no prior combination therapy comprising melphalan, dexamethasone, carmustine, cytarabine, and etoposide (dexa-beam)

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0025241 (melphalan)
SNOMED
544002
UMLS CUI [2]
C0011777 (dexamethasone)
SNOMED
7561000
UMLS CUI [3]
C0007257 (carmustine)
SNOMED
51326002
UMLS CUI [4]
C0010711 (cytarabine)
SNOMED
89265009
UMLS CUI [5]
C0015133 (etoposide)
SNOMED
56928005
no more than 1 prior chemotherapy regimen
Descrizione

no more than 1 prior chemotherapy regimen

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0392920 (Chemotherapy Regimen)
SNOMED
716872004
no prior chemotherapy regimen longer than 6 months in duration
Descrizione

no prior chemotherapy regimen longer than 6 months in duration

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0392920 (Chemotherapy Regimen)
SNOMED
716872004

Similar models

Eligibility Leukemia NCT00275015

  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00275015
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
CLL
Item
patients with chronic lymphocytic leukemia, meeting 1 of the following criteria:
boolean
C0023434 (UMLS CUI [1])
binet stage
Item
binet stage b or c disease
boolean
C1511118 (UMLS CUI [1])
binet stage a disease and at high risk for disease progression
Item
binet stage a disease and at high risk for disease progression, defined as the following:
boolean
C1511118 (UMLS CUI [1])
non-nodular marrow infiltration or lymphocyte doubling time < 12 months
Item
non-nodular marrow infiltration or lymphocyte doubling time < 12 months
boolean
C3854434 (UMLS CUI [1])
C2986483 (UMLS CUI [2])
thymidine kinase, ß-2-microglobulin
Item
thymidine kinase > 7.0 u/l or ß-2-microglobulin > 3.5 mg/l
boolean
C0040078 (UMLS CUI [1])
C0005149 (UMLS CUI [2])
polymerase chain reaction-amplifiable clonal cdriii rearrangement of the igv_h
Item
polymerase chain reaction-amplifiable clonal cdriii rearrangement of the igv_h
boolean
C0887928 (UMLS CUI [1])
ecog performance status
Item
ecog performance status 0-1
boolean
C1520224 (UMLS CUI [1])
no concurrent disease resulting in major organ dysfunction
Item
no concurrent disease resulting in major organ dysfunction
boolean
C0009488 (UMLS CUI [1])
no prior combination therapy comprising melphalan, dexamethasone, carmustine, cytarabine, and etoposide (dexa-beam)
Item
no prior combination therapy comprising melphalan, dexamethasone, carmustine, cytarabine, and etoposide (dexa-beam)
boolean
C0025241 (UMLS CUI [1])
C0011777 (UMLS CUI [2])
C0007257 (UMLS CUI [3])
C0010711 (UMLS CUI [4])
C0015133 (UMLS CUI [5])
no more than 1 prior chemotherapy regimen
Item
no more than 1 prior chemotherapy regimen
boolean
C0392920 (UMLS CUI [1])
no prior chemotherapy regimen longer than 6 months in duration
Item
no prior chemotherapy regimen longer than 6 months in duration
boolean
C0392920 (UMLS CUI [1])

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial